By Jesús Avila
Content material: Preface; Animal versions on Alzheimer disorder; Animal versions for Amyloid/PS-1 Pathology; Transgenic mice overexpressing GSK-3beta as animal types of Alzheimer sickness; Reelin and Alzheimer ailment; Tauopathy types; Animal types for Parkinson sickness I; Animal types for Parkinson affliction II; Neuroprotection in Parkinson disorder; Animal versions for ALS; Mouse types of Huntington's ailment; Recesive Ataxias; Mouse versions in PrP-related ailments; Mouse versions of ischemia
Read or Download Animal Models for Neurodegenerative Disease PDF
Similar biochemistry books
Biochemical research is a quickly increasing box and is a key component to smooth drug discovery and study. tools of Biochemical research presents a periodic and authoritative assessment of the newest achievements in biochemical research. based in 1954 via Professor David Glick, equipment of Biochemical research presents a well timed assessment of the newest advancements within the box.
During this quantity, in vitro types for the learn of lymphoid cellphone services and techniques for the learn of lymphoid phone receptors are provided. Lymphocyte in vitro transformation is mentioned within the first part that describes tools for the in vitro stimulation of lymphocytes. a few exact media for the learn of lymphocyte transformation also are mentioned.
- The Biochemistry of Inorganic Polyphosphates, Second Edition
- Epstein-Barr Virus Protocols
- Caspases,Paracaspases, and Metacaspases: Methods and Protocols
- Biomembranes Part B
- C. elegans: Methods and Applications
Additional info for Animal Models for Neurodegenerative Disease
Bodai, J. Pallos, M. Poelman, A. McCampbell, B. L. Apostol, A. Kazantsev, E. Schmidt, Y. Z. Zhu, M. Greenwald, R. Kurokawa, D. E. Housman, G. R. Jackson, J. L. Marsh and L. M. Thompson, Nature, 2001, 413, 739–743. 80. R. J. Ferrante, J. K. Kubilus, J. Lee, H. Ryu, A. Beesen, B. Zucker, K. Smith, N. W. Kowall, R. R. Ratan, R. Luthi-Carter and S. M. Hersch, J. , 2003, 23, 9418–9427. 81. G. Gardian, L. Yang, C. Cleren, N. Y. Calingasan, P. Klivenyi and M. F. , 2004, 5, 235–242. 14 Chapter 1 82. S.
121. E. Hama, K. Shirotani, H. Masumoto, Y. Sekine-Aizawa, H. Aizawa and T. C. Saido, J. , 2001, 130(6), 721–726. 122. N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N. P. Gerard, C. Gerard, E. Hama, H. J. Lee and T. C. Saido, Science, 2001, 292(5521), 1550–1552. 123. W. J. Meilandt, M. Cisse, K. Ho, T. Wu, L. A. Esposito, K. ScearceLevie, I. H. Cheng, G. Q. Yu and L. Mucke, J. , 2009, 29(7), 1977–1986. 124. B. A. Bergmans and B. , 9(2), 215–226. 36 Chapter 2 125. O. Murayama, T. Tomita, N.
Price, V. Holloway, L. Smithson, B. L. Dicker, M. J. During, D. Young and T. E. Golde, Mol. , 2007, 2, 11. 105. P. A. Lewis, S. Piper, M. Baker, L. Onstead, M. P. Murphy, J. Hardy, R. Wang, E. McGowan and T. E. Golde, Biochim. Biophys. Acta, 2001, 1537(1), 58–62. 106. R. Vidal, B. Frangione, A. Rostagno, S. Mead, T. Revesz, G. Plant and J. Ghiso, Nature, 1999, 399(6738), 776–781. Animal Models of Amyloid/PS-1 Pathology 35 107. R. Vidal, T. Revesz, A. Rostagno, E. Kim, J. L. Holton, T. Bek, M. Bojsen-Moller, H.
Animal Models for Neurodegenerative Disease by Jesús Avila